![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 6, 3268-3271, February 5, 1999
,
,
,
From the Macrophage migration inhibitory factor (MIF) is a
relatively small, 12.5-kDa protein that is structurally related to some isomerases and for which multiple immune and catalytic roles have been
proposed. MIF is widely expressed in tissues with particularly high
levels in neural tissues. Here we show that MIF is able to catalyze the
conversion of 3,4-dihydroxyphenylaminechrome and norepinephrinechrome, toxic quinone products of the neurotransmitter catecholamines 3,4-dihydroxyphenylamine and norepinephrine, to indoledihydroxy derivatives that may serve as precursors to
neuromelanin. This raises the possibility that MIF participates in a
detoxification pathway for catecholamine products and could therefore
have a protective role in neural tissues, which as in Parkinson's
disease, may be subject to catecholamine-related cell death.
Pigment Cell Biology Section,
Department of Biochemistry,
University of Murcia, E-30100 Murcia, Spain
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
This article has been cited by other articles:
![]() |
X. Zang, P. Taylor, J. M. Wang, D. J. Meyer, A. L. Scott, M. D. Walkinshaw, and R. M. Maizels Homologues of Human Macrophage Migration Inhibitory Factor from a Parasitic Nematode. GENE CLONING, PROTEIN ACTIVITY, AND CRYSTAL STRUCTURE J. Biol. Chem., November 8, 2002; 277(46): 44261 - 44267. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Lubetsky, A. Dios, J. Han, B. Aljabari, B. Ruzsicska, R. Mitchell, E. Lolis, and Y. Al-Abed The Tautomerase Active Site of Macrophage Migration Inhibitory Factor Is a Potential Target for Discovery of Novel Anti-inflammatory Agents J. Biol. Chem., July 5, 2002; 277(28): 24976 - 24982. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Isidori, G. A. Kaltsas, M. Korbonits, M. Pyle, M. Gueorguiev, A. Meinhardt, C. Metz, N. Petrovsky, V. Popovic, R. Bucala, et al. Response of Serum Macrophage Migration Inhibitory Factor Levels to Stimulation or Suppression of the Hypothalamo-Pituitary-Adrenal Axis in Normal Subjects and Patients with Cushing's Disease J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1834 - 1840. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Senter, Y. Al-Abed, C. N. Metz, F. Benigni, R. A. Mitchell, J. Chesney, J. Han, C. G. Gartner, S. D. Nelson, G. J. Todaro, et al. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites PNAS, January 1, 2002; (2002) 11569399. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Zecca, D Tampellini, M Gerlach, P Riederer, R G Fariello, and D Sulzer Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour Mol. Pathol., December 1, 2001; 54(6): 414 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Busche, S. Gallinat, M. A. Fleegal, M. K. Raizada, and C. Sumners Novel Role of Macrophage Migration Inhibitory Factor in Angiotensin II Regulation of Neuromodulation in Rat Brain Endocrinology, November 1, 2001; 142(11): 4623 - 4630. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Senter, Y. Al-Abed, C. N. Metz, F. Benigni, R. A. Mitchell, J. Chesney, J. Han, C. G. Gartner, S. D. Nelson, G. J. Todaro, et al. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites PNAS, January 8, 2002; 99(1): 144 - 149. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |